• Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact
Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer
  • Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact

Archives

Monthly Archive for: "September, 2014"
 Nascent team members author “Oligoclonal and Polyclonal Antibody Preparations” paper
0
By Nascent Biotech
In Science News
Posted September 8, 2014

Nascent team members author “Oligoclonal and Polyclonal Antibody Preparations” paper

Nascent founder and chief executive officer Dr. Mark C. Glassy and chief science officer Dr. Rishab K. Gupta authored a new paper published in the Handbook of Therapeutic Antibodies, Second [...]

READ MORE
 Nascent Team Members Contribute to “Human Monoclonal Antibodies” (Humana Press)
0
By Nascent Biotech
In Science News
Posted September 8, 2014

Nascent Team Members Contribute to “Human Monoclonal Antibodies” (Humana Press)

Nascent founder and chief executive officer Dr. Mark C. Glassy and chief science officer Dr. Rishab K. Gupta have contributed a chapter to Humana Press’ new book “Human Monoclonal [...]

READ MORE
© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.